Published in Medical Device Business Week, September 29th, 2004
The novel wound management device for leg and foot ulcers will be marketed by Teva Medical to all sectors of the healthcare community in Israel. The terms of the deal include an undisclosed upfront payment to Ark, minimum annual order levels and profits from commercialization being shared between the two companies.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Device Business Week